Skip to main content

Table 3 Prevalence (%) of active headache disorder by type, gender and timeframe

From: The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates

Timeframe

Headache

Migraine

TTH

H15+

N

Mean

95% CI

N

Mean

95% CI

N

Mean

95% CI/

N

Mean

95% CI

Lifetime

 Both genders

42

66.6

58.8–73.9

49

17.5

14.6–21.0

18

40.6

30.0–51.4

9

4.5

1.8–7.7

 Males

28

65.0

53.8–74.4

39

11.6

9.1–14.8

9

35.7

19.6–52.6

6

1.9

0.9–3.1

 Females

28

73.3

63.3–83.2

41

21.0

17.3–25.4

9

43.8

26.5–61.8

6

4.5

2.2–7.5

1-year

 Both genders

110

53.5

49.1–57.7

150

15.3

13.7–16.9

77

26.4

22.9–30.3

50

4.8

4.0–5.7

 Males

73

46.4

41.1–51.7

112

9.1

7.9–10.3

47

24.2

19.2–29.6

39

2.9

2.2–3.8

 Females

72

60.5

55.1–65.8

113

18.1

16.3–29.9

48

28.5

22.7–34.3

39

6.2

4.9–7.6

6-month, both genders

15

60.9

50.6–71.3

12

11.1

6.7–16.9

9

32.2

15.1–50.8

2

6.0

4.8–7.2

3-month, both genders

12

52.2

36.5–66.6

10

13.4

9.1–17.9

5

20.2

2.1–38.6

3

2.7

2.2–3.3

“Current”, both genders

3

37.2

10

12.9

7.7–18.3

0

0

Unknown, both genders

43

45.9

38.5–53.1

62

11.9

10.0–14.0

19

22.9

17.2–29.2

4

3.4

1.5–5.4

1-day

 Both genders

12

15.8

10.0–22.0

5

7.0

4

8.7

3

2.5

 Males

8

8.0

4.0–12.8

2

2.4

1

5.1

1

1.8

 Females

8

14.9

8.9–21.7

2

5.5

1

10.1

1

4.4

All timeframes, both genders

237

52.7

49.7–55.8

298

14.5

13.4–15.5

132

27.4

24.2–30.9

71

4.5

3.9–5.2

  1. N number of studies, TTH tension-type headache, H15+ headache on ≥15 days/month, CI confidence interval (not given when N ≤ 5)